Biofil Chemicals Approves Directorship Continuation of Ashok Kumar Ramawat
Biofil Chemicals & Pharmaceuticals Ltd 路 Change in Management 路 24 Sept 2026, 11:20 pm
Biofil Chemicals Approves Directorship Continuation of Ashok Kumar Ramawat Biofil Chemicals and Pharmaceuticals Limited announced that shareholders approved the continuation of Mr. Ashok Kumar Ramawat as a Non-Executive Independent Director at the 41st AGM held on 23rd Sep'26. The approval complies with SEBI Regulation 17(1A) concerning directorship continuation upon reaching 75 years of age on 27th Sep'27. Mr. Ramawat holds a Bachelor's Degree in Science, brings 46 years of pharmaceutical industry experience, and has no familial relationships with existing directors or key managerial personnel.
Original exchange filing (PDF)
More announcements from Biofil Chemicals & Pharmaceuticals Ltd
- Biofil Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- To review, consider and approve the Standalone Unaudited Financial Results for the quarter and half year ended on 30th September 2026 along with limited review report 路 15 Nov 2026
- To review, consider and approve the Standalone Unaudited Financial Results for the quarter and half year ended on 30th September 2026 along with Limited Review Report. 路 15 Nov 2026
- BIOFIL CHEMICALS & PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 14 Nov 2026
- Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Unaudited .... 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 14 Nov 2026
- Scruitinizer report with voting results 路 24 Sept 2026
- Summary of Proceedings of 41st Annual General Meeting of the company held on Wednesday, 23rd September 2026 pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI .... 路 23 Sept 2026
